Tower Research Capital »

Titan Pharmaceuticals Inc Del shares owned by Tower Research Capital

Quarter-by-quarter ownership of Titan Pharmaceuticals Inc Del shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Titan Pharmaceuticals Inc Del

Tip: Access up to 7 years of quarterly data

All positions including Titan Pharmaceuticals Inc Del held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Titan Pharmaceuticals Inc Del by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.2k 469 4.79
2024-09-30 $3.9k 743 5.27
2024-06-30 $4.0k 717 5.57
2024-03-31 $4.6k 647 7.16

More positions owned by Tower Research Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Direxion Shs Etf Tr Dly Scond 3xbu (SOXL)
Alphabet Cap Stk Cl A (GOOGL)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Vanguard Instl Index 0-3 Mo Treas Bil (VBIL)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr 0-3 Mnth Treasry (SGOV)

View all positions for Tower Research Capital

Top funds holding Titan Pharmaceuticals Inc Del

DRW Holdings
UBS Group
Tower Research Capital
CoreCap Advisors
Group One Trading
Advisor Group Holdings
BlackRock
Morgan Stanley
Global Wealth Strategies & Associates
Caldwell Sutter Capital
Ransom Advisory
D. J. St. Germain
CWM
SBI Securities
Westside Investment Management

View all funds holding Titan Pharmaceuticals Inc Del